IL-2 liposome formulations suitable for aerosol delivery are described. Also described are methods of treating patients with immune deficiency conditions or chronic viral infections, such as hepatitis C, by the administration of such aerosolized IL-2 liposome formulations. The IL-2 liposome formulations can be self-administered by the patient. Also described are kits including the IL-2 liposome formulations.
申请公布号
WO02078624(A2)
申请公布日期
2002.10.10
申请号
WO2002US09129
申请日期
2002.03.26
申请人
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH;ZEIN, NIZAR, N.;ANDERSON, PETER, M.
